EXAS vs LXU · rev $2.76B vs rev $337.6M
EXACT Sciences Corporation (EXAS) versus Lsb Industries Inc (LXU) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Lsb Industries Inc (LXU) is a chemicals company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported LXU revenue for 2026-06-30 was $337.6M. Net income was $13.5M. Revenue was up 99.2% from 2026-03-31 to 2026-06-30. LXU currently screens at market cap $590.8M.
EXAS currently screens at market cap $20.03B. LXU currently screens at market cap $590.8M.
Not investment advice. Open the EXAS and LXU stock pages for the full models.
Not investment advice.